Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an iPad app boost brain power after tumor treatment?

NCT ID NCT03948490

Recruiting now Symptom relief Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 15, 2026 · Updated 3 times

Summary

This study tests three ways to help adults with low-grade glioma improve memory and attention: an iPad app (ReMind), daily health text messages, and in-person cognitive rehab. About 97 participants will try one of these programs for several weeks, and researchers will track their cognitive skills over 36 months. The goal is to see if these approaches are feasible and can ease the thinking problems caused by brain tumors and their treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ReMind iPad app, Healthy SMS texting, and in-person cognitive rehabilitation
What this could lead to
If successful, this could establish a standard approach to help brain tumor patients improve memory and attention, enhancing their quality of life.
What could go wrong
This is an early feasibility study with only 97 participants, so results may not apply broadly. The interventions may not show meaningful cognitive improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW GRADE GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction low grade glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOW GRADE GLIOMA

Contacts and locations

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.